417 related articles for article (PubMed ID: 24713153)
1. Impact of transcatheter closure of patent foramen ovale in the evolution of migraine and role of residual shunt.
Biasco L; Infantino V; Orzan F; Vicentini S; Rovera C; Longo G; Chinaglia A; Belli R; Allais G; Gaita F
J Cardiol; 2014 Nov; 64(5):390-4. PubMed ID: 24713153
[TBL] [Abstract][Full Text] [Related]
2. Primary transcatheter patent foramen ovale closure is effective in improving migraine in patients with high-risk anatomic and functional characteristics for paradoxical embolism.
Rigatelli G; Dell'Avvocata F; Ronco F; Cardaioli P; Giordan M; Braggion G; Aggio S; Chinaglia M; Rigatelli G; Chen JP
JACC Cardiovasc Interv; 2010 Mar; 3(3):282-7. PubMed ID: 20298985
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous Closure of Patent Foramen Ovale in Patients With Migraine: The PREMIUM Trial.
Tobis JM; Charles A; Silberstein SD; Sorensen S; Maini B; Horwitz PA; Gurley JC
J Am Coll Cardiol; 2017 Dec; 70(22):2766-2774. PubMed ID: 29191325
[TBL] [Abstract][Full Text] [Related]
4. Improvement of migraine headaches after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism.
Wahl A; Praz F; Tai T; Findling O; Walpoth N; Nedeltchev K; Schwerzmann M; Windecker S; Mattle HP; Meier B
Heart; 2010 Jun; 96(12):967-73. PubMed ID: 20538672
[TBL] [Abstract][Full Text] [Related]
5. Comparison of residual shunt rates in five devices used to treat patent foramen ovale.
Matsumura K; Gevorgyan R; Mangels D; Masoomi R; Mojadidi MK; Tobis J
Catheter Cardiovasc Interv; 2014 Sep; 84(3):455-63. PubMed ID: 24550064
[TBL] [Abstract][Full Text] [Related]
6. Frequency of migraine headache relief following patent foramen ovale "closure" despite residual right-to-left shunt.
Jesurum JT; Fuller CJ; Kim CJ; Krabill KA; Spencer MP; Olsen JV; Likosky WH; Reisman M
Am J Cardiol; 2008 Oct; 102(7):916-20. PubMed ID: 18805122
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of transcatheter patent foramen ovale closure in migraineurs with moderate to large right-to-left shunt and instrumental evidence of cerebrovascular damage.
Papa M; Gaspardone A; Fragasso G; Ajello S; Gioffrè G; Iamele M; Iani C; Margonato A
Am J Cardiol; 2009 Aug; 104(3):434-9. PubMed ID: 19616680
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and Safety of Transcatheter Patent Foramen Ovale Closure for Migraine (EASTFORM) Trial.
Xing YQ; Guo YZ; Gao YS; Guo ZN; Niu PP; Yang Y
Sci Rep; 2016 Dec; 6():39081. PubMed ID: 27966652
[TBL] [Abstract][Full Text] [Related]
9. Effect of Residual Interatrial Shunt on Migraine Burden After Transcatheter Closure of Patent Foramen Ovale.
Ben-Assa E; Rengifo-Moreno P; Al-Bawardy R; Kolte D; Cigarroa R; Cruz-Gonzalez I; Sakhuja R; Elmariah S; Pomerantsev E; Vaina LM; Ning M; Buonanno FS; Hung JW; Inglessis I; Palacios IF
JACC Cardiovasc Interv; 2020 Feb; 13(3):293-302. PubMed ID: 32029246
[TBL] [Abstract][Full Text] [Related]
10. Transcranial Doppler quantification of residual shunt after percutaneous patent foramen ovale closure. Comparison of two devices.
Sorensen SG; Aguilar H; McKnight WK; Thomas H; Muhlestein JB
J Interv Cardiol; 2010 Dec; 23(6):575-80. PubMed ID: 20796165
[TBL] [Abstract][Full Text] [Related]
11. Improvement of migraine after patent foramen ovale percutaneous closure in patients with subclinical brain lesions: a case-control study.
Vigna C; Marchese N; Inchingolo V; Giannatempo GM; Pacilli MA; Di Viesti P; Impagliatelli M; Natali R; Russo A; Fanelli R; Loperfido F
JACC Cardiovasc Interv; 2009 Feb; 2(2):107-13. PubMed ID: 19463410
[TBL] [Abstract][Full Text] [Related]
12. Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature.
Manolis AS
Rev Recent Clin Trials; 2017; 12(2):129-138. PubMed ID: 28356032
[TBL] [Abstract][Full Text] [Related]
13. ICE-guided patent foramen ovale (PFO) closure with lastest-generation devices: the ideal strategy for PFO-related migraine?
Rigatelli G; Cardaioli P; Braggion G; Giordan M; Aggio S; Roncon L
J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):633-5. PubMed ID: 17667037
[TBL] [Abstract][Full Text] [Related]
14. Resolution of migraine by transcatheter patent foramen ovale closure with Premere Occlusion System in a preliminary series of patients with previous cerebral ischemia.
Rigatelli G; Cardaioli P; Braggion G; Giordan M; Fabio D; Aggio S; Roncon L; Chinaglia M
Catheter Cardiovasc Interv; 2007 Sep; 70(3):429-33. PubMed ID: 17722021
[TBL] [Abstract][Full Text] [Related]
15. Second transcatheter closure for residual shunt following percutaneous closure of patent foramen ovale.
Susuri N; Obeid S; Ulmi M; Siontis GCM; Wahl A; Windecker S; Nietlispach F; Meier B; Praz F
EuroIntervention; 2017 Sep; 13(7):858-866. PubMed ID: 28437244
[TBL] [Abstract][Full Text] [Related]
16. Transcatheter patent foramen ovale closure is effective in reducing migraine independently from specific interatrial septum anatomy and closure devices design.
Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Braggion G; Chinaglia M; Roncon L
Cardiovasc Revasc Med; 2010; 11(1):29-33. PubMed ID: 20129358
[TBL] [Abstract][Full Text] [Related]
17. Permanent right-to-left shunt is the key factor in managing patent foramen ovale.
Rigatelli G; Dell'Avvocata F; Cardaioli P; Giordan M; Braggion G; Aggio S; Chinaglia M; Mandapaka S; Kuruvilla J; Chen JP; Nanjundappa A
J Am Coll Cardiol; 2011 Nov; 58(21):2257-61. PubMed ID: 22078434
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous closure of patent foramen ovale for migraine headaches refractory to medical treatment.
Wahl A; Praz F; Findling O; Nedeltchev K; Schwerzmann M; Tai T; Windecker S; Mattle HP; Meier B
Catheter Cardiovasc Interv; 2009 Jul; 74(1):124-9. PubMed ID: 19180663
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of randomized trials on percutaneous patent foramen ovale closure for prevention of migraine.
Elbadawi A; Barssoum K; Abuzaid AS; Rezq A; Biniwale N; Alotaki E; Mohamed AH; Vuyyala S; Ogunbayo GO; Saad M
Acta Cardiol; 2019 Apr; 74(2):124-129. PubMed ID: 29914296
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of percutaneous closure of patent foramen ovale for hypoxemia.
Fenster BE; Nguyen BH; Buckner JK; Freeman AM; Carroll JD
Am J Cardiol; 2013 Oct; 112(8):1258-62. PubMed ID: 23871675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]